Sera Prognostics (SERA) Long-Term Debt Issuances (2020 - 2021)

Sera Prognostics (SERA) posted Long-Term Debt Issuances of $3.1 million for Q1 2021, up 395.24% on a QoQ basis from -$1.0 million in Q3 2020.

Sera Prognostics (SERA) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends

Sera Prognostics' Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $3.1 million for Q1 2021.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $3.1 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $3.1 million (changed N/A YoY) and the FY2021 annual result came in at $3.1 million, changed N/A from the prior year.
Long-Term Debt Issuances was $3.1 million for Q1 2021 at Sera Prognostics, up from -$1.0 million in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $3.1 million in Q1 2021 and bottomed at -$1.0 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	184.10 Bn	176.81 Bn	6.27 Bn	19.86 Bn
2	Stryker	128.79 Bn	125.91 Bn	3.81 Bn	-
3	Medtronic	108.97 Bn	99.75 Bn	6.41 Bn	-
4	Boston Scientific	68.57 Bn	67.12 Bn	3.61 Bn	-
5	Edwards Lifesciences	47.64 Bn	43.97 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.40 Bn	26.11 Bn	1.98 Bn	1.15 Bn
7	Dexcom	28.32 Bn	27.20 Bn	750.30 Mn	-
8	Smith & Nephew	26.94 Bn	26.36 Bn	-	-
9	Koninklijke Philips	25.45 Bn	22.33 Bn	2.07 Bn	11.71 Mn
10	Sera Prognostics	102.28 Mn	102.28 Mn	-28,000.00	-

Download Data